Burkitt's lymphoma is a rare and aggressive blood cancer characterized by a translocation of the MYC gene. It occurs most often in children and young adults. In recent years, CAR-T cell therapy—often ...

A 72-year-old patient with Burkitt lymphoma was successfully treated with nivolumab after standard-of-care chemotherapy failed. A new case report is raising the possibility that nivolumab (Opdivo) may ...

Dear Doctor: Could you tell me about the causes, treatment and remission rates for Burkitt lymphoma? Dear Reader: Burkitt lymphoma is a highly aggressive, rapidly growing type of B cell lymphoma. It’s ...

Treatment schedule in an immunocompetent mouse model bearing a high burden of Burkitt’s lymphoma. While conventional CAR-T therapy alone resulted in no cures, adding five doses of a SUMOylation ...

Burkitt’s lymphoma is a rapidly proliferating lymphoma of germinal-center B cells. Most patients are cured with chemotherapy and prevention of tumor lysis. Relapse and CNS involvement carry a poor ...

Burkitt lymphoma is an aggressive B-cell lymphoma requiring intensive therapy, which places patients at risk for severe toxicity. However, few studies have described these patients' clinical outcomes ...

Research into the most prevalent tumours in developing countries significantly lags behind research into those cancers that are more in Western countries, resulting in higher mortality rates. One such ...

Classifying non-Hodgkin lymphoma (NHL) can be confusing because there are so many types. The World Health Organization system is often used. It groups NHL by the appearance of the lymphoma cells, the ...

Burkitt lymphoma (BL) is a highly aggressive form of non-Hodgkin lymphoma (NHL) that comes in three different variants: endemic, immunodeficiency-associated, and sporadic. Of these variants, sporadic ...